AACP
PRVA icon

Advantage Alpha Capital Partners’s Privia Health PRVA Stock Holding History

Advantage Alpha Capital Partners’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-241,077
Closed -$6M – 87
2025
Q3 		$6M Buy
241,077
+69,720
+41% +$1.5M 1.81% 4
2025
Q2 		$3.94M Buy
+171,357
New +$3.97M 1.06% 41
2025
Q1 		– Sell
-115,227
Closed -$2.25M – 163
2024
Q4 		$2.25M Buy
+115,227
New +$2.28M 0.53% 73
2024
Q2 		– Sell
-262,824
Closed -$5.15M – 163
2024
Q1 		$5.15M Buy
262,824
+85,728
+48% +$1.81M 0.97% 44
2023
Q4 		$4.08M Buy
177,096
+22,879
+15% +$512K 0.77% 61
2023
Q3 		$3.55M Buy
154,217
+10,828
+8% +$275K 0.75% 67
2023
Q2 		$3.74M Buy
143,389
+817
+0.6% +$21.6K 0.75% 63
2023
Q1 		$3.94M Buy
142,572
+79,871
+127% +$2.11M 0.82% 59
2022
Q4 		$1.42M Sell
62,701
-42,936
-41% -$1.2M 0.29% 84
2022
Q3 		$3.6M Sell
105,637
-164,676
-61% -$6.09M 0.66% 57
2022
Q2 		$7.87M Buy
270,313
+42,745
+19% +$1.09M 1.36% 34
2022
Q1 		$6.08M Buy
227,568
+54,269
+31% +$1.28M 0.91% 53
2021
Q4 		$4.48M Buy
+173,299
New +$4.32M 0.64% 76

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advantage Alpha Capital Partners's PRVA Position: Q4 2025 in Review

Advantage Alpha Capital Partners sold out of Privia Health (PRVA) in Q4 2025, closing a stake of 241,077 shares — an estimated $6M sold.

Advantage Alpha Capital Partners first reported a position in PRVA in Q4 2021 and held it in 13 quarters. The position peaked at $7.87M in Q2 2022. 276 funds tracked by Wall St. Rank hold PRVA as of Q4 2025.

  • Advantage Alpha Capital Partners reported no remaining Privia Health position as of Q4 2025 after selling out during the quarter.
  • Advantage Alpha Capital Partners sold 241,077 Privia Health shares in Q4 2025, an estimated $6M.
  • Advantage Alpha Capital Partners first reported a position in Privia Health in Q4 2021 and held it in 13 quarters.
  • Advantage Alpha Capital Partners's Privia Health position peaked at $7.87M in Q2 2022.
  • 276 funds tracked by Wall St. Rank held Privia Health as of Q4 2025.

Based on Advantage Alpha Capital Partners's 13F filing for Q4 2025.